Document Detail

Immunotherapy for metastatic melanoma.
MedLine Citation:
PMID:  22006439     Owner:  NLM     Status:  Publisher    
Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of anti-tumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin-2, has resulted in prolonged responses in a small subset of patients, providing hope that immunotherapy might be useful for this disease. Ipilimumab, a monoclonal antibody to CTLA-4 was recently approved, and a number of other promising investigational approaches are currently being pursued. This manuscript discusses more recent advances in the treatment of melanoma employing a variety of immune-enhancing approaches. J. Cell. Biochem. © 2011 Wiley Periodicals, Inc.
Christopher Zito; Harriet M Kluger
Related Documents :
9850069 - Alpha-difluoromethylornithine inhibits n-nitrosomethylbenzylamine-induced esophageal ca...
21995459 - Hyper-interleukin-11 novel designer molecular adjuvant targeting gp130 for whole cell c...
22105649 - Establishing the carcinogenic risk of immunomodulatory drugs.
10226609 - Antitumor and antiproliferative effects of an aqueous extract from the marine diatom ha...
1841519 - Polyamine oxidase activity and concentration of polyamines in tissues and serum of hams...
22198309 - Exploiting antitumor immunity to overcome relapse and improve remission duration.
21498009 - Incidence of changes in respiration-induced tumor motion and its relationship with resp...
2678079 - Neutron capture therapy research in australia.
8566149 - G 619, a dual thromboxane synthase inhibitor and thromboxane a2 receptor antagonist, in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-17
Journal Detail:
Title:  Journal of cellular biochemistry     Volume:  -     ISSN:  1097-4644     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8205768     Medline TA:  J Cell Biochem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Wiley Periodicals, Inc.
Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06451.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of NavX on fluoroscopy times in pediatric catheter ablation.
Next Document:  The echinoid mitotic gradient: effect of cell size on the micromere cleavage cycle.